In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA OTC label comprehension, preference studies to involve over 2,000 subjects.

This article was originally published in The Tan Sheet

Executive Summary

FDA OTC LABEL COMPREHENSION, PREFERENCE STUDIES INVOLVING OVER 2,000 SUBJECTS will evaluate the format changes recently proposed by the agency and gather information about consumer preferences for label design variations. Two studies are planned, according to a May 12 FDA description of the research. The agency disclosed its intention to conduct consumer studies in its Feb. 27 proposal on OTC label reform ("The Tan Sheet" March 3, p. 1).





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts